Supplementary Table 2.

Multivariate Logistic Regression of Biofilm Status in the Primary Cohort (n = 756)

Multivariate logistic regression	Crude OR (95% CI)	Adjusted OR (95% CI)	P value
Age	0.99 (0.98–0.99)	1.00 (0.99–1.01)	.55
Female sex	1.35 (0.94–1.92)	1.04 (0.69–1.56)	.83
Irritable bowel syndrome (n = 86)	19.88 (8.59–46.01)	20.34 (8.72–47.42)	3.1 · 10–12a
UC (n = 102)	5.42 (2.35–12.49)	5.58 (2.41–12.94)	6.2 · 10–5a
Post-organ transplantation (n = 28)	3.55 (1.12–11.24)	3.47 (1.09–11.05)	.04b
Adenoma (n = 142)	2.64 (1.14–6.14)	2.54 (1.08–5.98)	.03b
Colorectal cancer (n = 26)	2.46 (0.65–8.55)	2.25 (0.62–8.22)	.22
Otherc (n = 49)	2.17 (0.74–6.35)	2.12 (0.72–6.25)	.17
Crohn’s disease (n = 82)	1.81 (0.68–4.8)	1.87 (0.7–4.99)	.21
Portal hypertension (n = 48)	1.86 (0.61–5.68)	1.85 (0.6–5.72)	.29
Diverticular disease (n = 29)	1.39 (0.35–5.6)	1.33 (0.33–5.41)	.69
GI bleeding (n = 52)	0.54 (0.11–2.65)	0.51 (0.1–2.54)	.41

CI, confidence interval; OR, odds ratio.

^aP ≤ .001.

^bP ≤ .05.

^cRepresenting microscopic, collagen, eosinophilic, and nonsteroidal anti-inflammatory drug–induced colitis, and GI infection– and chemotherapy-induced diarrhea.